Onco-Innovations Limited (NEO:ONCO)
1.100
0.00 (0.00%)
At close: May 8, 2026
Onco-Innovations Revenue
Onco-Innovations had revenue of 154.67K CAD in the twelve months ending January 31, 2026. In the fiscal year ending April 30, 2025, Onco-Innovations had annual revenue of 65.29K.
Revenue (ttm)
154.67K
Revenue Growth
n/a
P/S Ratio
423.63
Revenue / Employee
n/a
Employees
n/a
Market Cap
65.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 65.29K | - | - |
| Apr 30, 2024 | - | - | - |
| Apr 30, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOnco-Innovations News
- 2 days ago - Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology - Accesswire
- 5 days ago - Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation - Accesswire
- 9 days ago - Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies - Accesswire
- 12 days ago - Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program - Accesswire
- 17 days ago - Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies - Accesswire
- 19 days ago - Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program - Accesswire
- 23 days ago - Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development - Accesswire
- 4 weeks ago - Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy - Accesswire